High prevalence of circulating myositis-associated antibodies in non-COVID critical illness - 24/04/24
Doi : 10.1016/j.resmer.2024.101088
Alyssa Soskis a, 1, Mary B. Rice a, Donald B. Bloch b, Rachel K. Putman c, Antonio Arciniegas Rubio c, Katherin Zambrano Vera c, Rene S. Bermea b, Andrew J. Sauer b, Claire O. Sinow b, Max Shen a, Mayra Pinilla Vera c, Rebecca M. Baron c, Robert W. Hallowell b, ⁎ 
a Beth Israel Deaconess Medical Center, Boston, MA, USA
b Massachusetts General Hospital, Boston, MA, USA
c Brigham and Women's Hospital, Boston, MA, USA
⁎Corresponding author.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Keywords : Acute respiratory distress syndrome, Myositis, Autoantibodies, COVID-19, Interstitial lung disease
Esquema
| Funding sources: The Sidney and Deanna Wolk Family Fund for Translational Research in Interstitial Lung Disease; Luisa Hunnewell; Larry Newman and The Feil Family Foundation. |
© 2024
The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 85
Artículo 101088- juin 2024 Regresar al número
Artículo precedente
- Efficacy and safety of different inhaled corticosteroids for bronchopulmonary dysplasia prevention in preterm infants: A systematic review and meta-analysis
- Minghai Zhang, Wei Zhang, Hongqun Liao
- Comparison of ChatGPT version 3.5 & 4 for utility in respiratory medicine education using clinical case scenarios
- Gayathri Balasanjeevi, Krishna Mohan Surapaneni
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.